Galacto-oligosaccharide Market to grow at a CAGR of 10.29% during 2024-2028
The Galacto-oligosaccharide Market is expected to grow at a CAGR of 10.29% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 746.25 million. In the realm of nutraceuticals, these value-added products serve a dual purpose, acting both as nutritional supplements and therapeutic agents. Galacto-oligosaccharides (GOS), a type of prebiotic nutraceutical, offer significant benefits in the healthcare sector. With their ability to promote the growth of beneficial bacteria in the gut, GOS contribute to the prevention and management of chronic diseases such as obesity and cardiovascular disorders. Additionally, they provide a natural sweetening alternative for individuals with diabetes, offering a sweet taste without raising blood glucose levels. The expanding adoption of nutraceuticals, particularly prebiotics like GOS, is a testament to their potential in enhancing overall health and wellness.
Get more information on Galacto-oligosaccharide Market by requesting a sample report
Technavio analysts predict that the Syrup subsegment will lead the Product segment during 2024 and 2028 In the business context, the syrup form of galacto-oligosaccharides (GOS) offers several advantages over the powder form. GOS syrups are easily consumed, particularly by children, due to their pleasant liquid consistency. The high solubility of GOS in water facilitates easy dissolution during intake, making it an ideal choice for food and beverage applications. Moreover, the syrup form enables the stable and effective incorporation of unstable or degradable ingredients, which may not be feasible in the powder form. Furthermore, for products that contain ingredients with unpleasant tastes or odors, the syrup form is the preferred choice as it masks these sensory attributes, enhancing consumer acceptance.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish increasing need for supplementary nutrients among infants
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
The Galacto-oligosaccharide (GOS) market is experiencing significant growth due to increasing health-consciousness among consumers, particularly in the infant population and the younger generation. Companies like Stratum Nutrition and Clasado Biosciences are leading the way with innovative prebiotic-postbiotic solutions, such as Stratum's LBiome GOS. These GOS are digestion-resistant, making them ideal for promoting the growth of beneficial bacteria like Bifidobacteria and Intestinal Lactobacilli, which improve fecal pH and overall gut health. GOS find applications in various industries, including baby formula, where they serve as a low-calorie sweetener and fortifier. They are also used in confectionery, fortified foods, and beverages, such as cereals, ice creams, dairy products, and bars. The market for GOS is expanding beyond food and beverages, with potential applications in cosmetics and pharmaceuticals, including drugs and cosmeceuticals. The GRAS status of GOS, as recognized by the Federal Food and Drug Administration (FDA) and the Cosmetic Act, further boosts market growth. Isomaltooligosaccharide (IMO), another type of prebiotic, is also gaining popularity in the market due to its unique health benefits.
According to Technavio, the global galacto-oligosaccharide market is positioned within the expansive healthcare industry, specifically the pharmaceuticals sector. The pharmaceuticals market encompasses entities involved in research and development (R&D) or manufacturing of various offerings, including generic and non-generic drugs, veterinary medicines, and biotechnology products. The healthcare industry's overall size is determined by Technavio based on the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Key growth drivers for the global pharmaceuticals market include the increasing elderly population, with the number of individuals aged 60 years and above projected to surge significantly.
The Galacto-oligosaccharide Market is experiencing significant growth, fueled by the increasing need for supplementary nutrients among infants. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
